| Drug/DM | Brand name | INN | Pharmaceutical form | Strengths | Primary packaging | Therapeutic area |
CTD Dossier availability |
GMP |
Climatic zone |
|---|---|---|---|---|---|---|---|---|---|
| Drug | CITOCON® | Citicoline |
Solution for injection |
125 mg/ml, |
Ampoules |
Nervous system | Available |
UA - available |
IVb |
| Drug | SUFER® | Iron sucrose solution |
Solution for injection |
20 mg/ml, |
Ampoules |
Antianemic preparations |
Q1 2027 |
UA -available EU - Q4 2028 |
II |
| Drug | XAVRON® | Edaravone |
Solution for injection |
1,5 mg/ml, 20 ml |
Ampoules |
Nervous system | Q4 2025 |
UA - available |
IVb |